Results 201 to 210 of about 296,469 (371)

Very Early‐Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In a multicentre cohort of patients with unifocal HCC, patients with very early stage disease had a survival advantage over patients diagnosed at an early stage. Factors associated with mortality included worse liver function, larger tumour size and higher AFP levels.
Thomas Hunold   +4 more
wiley   +1 more source

HCV medication affected by Genetic Variations in Host factors

open access: yesResearch in Molecular Medicine, 2017
Although standard treatments are nearly life-saving in hepatitis C patients, all patients equally don’t respond to such medications. To achieve a favorable therapeutic response in all patients, medications might alter between individuals based on ...
Maryam Karkhane   +3 more
doaj  

Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents. [PDF]

open access: yesJGH Open, 2022
Hattori N   +14 more
europepmc   +1 more source

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Indocyanine green clearance by pulse dye densitometry correlates with portal hypertension, systemic inflammation and circulatory dysfunction in advanced chronic liver disease. While diagnostic accuracy for CSPH was limited, ICG‐R15 independently predicted decompensation and ACLF/liver‐related mortality, highlighting its prognostic value across disease ...
Mathias Jachs   +17 more
wiley   +1 more source

Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Serum HBV RNA levels at viral suppression predict HCC development in nucleos(t)ide analogue‐treated patients with chronic hepatitis B, outperforming Hepatitis B core‐related antigen alone. ABSTRACT Background Despite achieving undetectable hepatitis B virus (HBV) DNA levels with nucleos(t)ide analogue (NA) therapy, patients with chronic hepatitis B ...
Takashi Kumada   +6 more
wiley   +1 more source

Relation between C.32 A>T Polymorphism In TLR7 and Response to Treatment in Chronic HCV-Infection

open access: yesArmaghane Danesh Bimonthly Journal, 2009
ABESTRACT: Introduction & Objective: Hepatitis C virus (HCV)-infection leads to development of chronic hepatitis, liver cirrhosis and hepatoma. Both the liver damage and extrahepatic manifestation of HCV are immune-mediated.
SA Taghavi   +3 more
doaj  

P-3 IMPACT OF THE SUSTAINED VIROLOGICAL RESPONSE ON THE GLUCOSE METABOLISM IN PATIENTS WITH HEPATITIS C

open access: gold, 2021
Fábia Benetti   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy